BioXclusters partners, along with some European SMEs, went to Boston (Massachusetts) last October 2013. Read the report we have produced with the description of the visits and information about the life sciences market.
The objective of the mission in Boston was to discover and detect key entry points of the biotech and medtech market in the USA and collaboration opportunities with the different organizations visited. The USA represents a key market in life sciences, and notably for Personalized Healthcare. With a life sciences sector weighting $61 billion and counting about 1.455 companies, among which 300 quoted in stock exchange, the USA is without any doubt the top-leading economy on this market.
The life sciences is indeed one of the most dynamic sector of the American economy were not less than $30 billion were invested for R&D in 2010. The American life sciences market alone accounts for 70% of the world turnover and for 15 % of the total sales of the biotechnologies market. Read more